Test Bank For
Pharmacotherapeutics For Advanced Practice Nurse Prescribers Fifth Edition
By Teri Moser Woo & Marylou V. Robinson( All Chapters Covered 1-55 With
Answer Section)
,table of contents
chapter 1. the role of the nurse practitioner ........................................................................... 4
chapter 2. review of basic principles of pharmacology............................................................ 5
chapter 3. rational drug selection ........................................................................................ 16
chapter 4. legal and professional issues in prescribing.......................................................... 19
chapter 5. adverse drug reactions ........................................................................................ 22
chapter 6. pharmacoeconomics ........................................................................................... 26
chapter 7. nutrition and nutraceuticals ................................................................................ 30
chapter 8. herbal therapy and nutritional supplements ........................................................ 40
chapter 9. informatics.......................................................................................................... 43
chapter 10. pharmacoeconomics ......................................................................................... 48
chapter 11. drugs affecting the autonomic nervous system .................................................. 52
chapter 12. drugs affecting the central nervous system ........................................................ 63
chapter 13. drugs affecting the cardiovascular and renal systems ........................................ 74
chapter 14. drugs affecting the respiratory system ............................................................... 86
chapter 15. drugs affecting the hematological system ......................................................... 92
chapter 16. drugs affecting the immune system ................................................................... 97
chapter 17. drugs affecting the gastrointestinal system ..................................................... 103
chapter 18. drugs affecting the endocrine system: pancreatic hormones and antidiabetic
drugs ................................................................................................................................. 107
chapter 19. drugs affecting the endocrine system: pituitary, thyroid, and adrenal drugs .... 113
chapter 20. drugs affecting the reproductive system .......................................................... 129
chapter 21. drugs affecting the bones and joints ................................................................ 136
chapter 22. drugs affecting the integumentary system ....................................................... 145
chapter 23. drugs used in treating bacterial diseases ......................................................... 151
chapter 24. drugs used to treat viral, fungal, and protozoal infections ............................... 158
chapter 25. drugs used in treating inflammatory processes ................................................ 165
chapter 26. drugs used in treating eye and ear disorders .................................................... 170
chapter 27. alcohol and drug addiction .............................................................................. 173
chapter 28. anemia............................................................................................................ 180
chapter 29. angina ............................................................................................................ 184
,chapter 30. anxiety and depression.................................................................................... 190
chapter 31. attention deficit hyperactivity disorder ............................................................ 194
chapter 32. asthma and chronic obstructive pulmonary disease ......................................... 198
chapter 33. contraception .................................................................................................. 202
chapter 34. dermatologic conditions .................................................................................. 205
chapter 35. diabetes management .................................................................................... 210
chapter 36. gastroesophageal reflux and peptic ulcer disease ............................................ 221
chapter 37. headaches ....................................................................................................... 225
chapter 38. heart failure .................................................................................................... 230
chapter 39. human immunodeficiency virus disease and acquired immunodeficiency ......... 235
chapter 40. hormone replacement therapy ........................................................................ 239
chapter 41. hyperlipidemia ................................................................................................ 244
chapter 42. hypertension ................................................................................................... 249
chapter 43. hyperthyroidism and hypothyroidism .............................................................. 255
chapter 44. pain management: acute and chronic pain ...................................................... 259
chapter 45. pneumonia ...................................................................................................... 264
chapter 46. smoking cessation ........................................................................................... 267
chapter 47. sexually transmitted infections and vaginitis ................................................... 270
chapter 48. tuberculosis..................................................................................................... 275
chapter 49. upper respiratory infection, pharyngitis, sinusitis, otitis media, and otitis externa
......................................................................................................................................... 278
chapter 50. urinary tract infections .................................................................................... 282
chapter 51: women as patients .......................................................................................... 285
chapter 52. men as patients ............................................................................................... 290
chapter 53. pediatric patients ............................................................................................ 293
chapter 54. transgendered clients as patients .................................................................... 296
chapter 55. geriatric patients ............................................................................................. 301
,chapter 1. the role of the nurse practitioner
multiple choice
identify the choice that best completes the statement or answers the question.
1. nurse practitioner prescriptive authority is regulated by:
1. the national council of state boards of nursing
2. the u.s. drug enforcement administration
3. the state board of nursing for each state
4. the state board of pharmacy
2. the benefits to the patient of having an advanced practice registered nurse (aprn)
prescriber include:
1. nurses know more about pharmacology than other prescribers because they take it
both in their basic nursing program and in their aprn program.
2. nurses care for the patient from a holistic approach and include the patient in decision
making regarding their care.
3. aprns are less likely to prescribe narcotics and other controlled substances.
4. aprns are able to prescribe independently in all states, whereas a physician’s assistant
needs to have a physician supervising their practice.
3. clinical judgment in prescribing includes:
1. factoring in the cost to the patient of the medication prescribed
2. always prescribing the newest medication available for the disease process
3. handing out drug samples to poor patients
4. prescribing all generic medications to cut costs
4. criteria for choosing an effective drug for a disorder include:
1. asking the patient what drug they think would work best for them
2. consulting nationally recognized guidelines for disease management
3. prescribing medications that are available as samples before writing a prescription
,4. following u.s. drug enforcement administration guidelines for prescribing
5. nurse practitioner practice may thrive under health-care reform because of:
1. the demonstrated ability of nurse practitioners to control costs and improve patient
outcomes
2. the fact that nurse practitioners will be able to practice independently
3. the fact that nurse practitioners will have full reimbursement under health-care
reform
4. the ability to shift accountability for medicaid to the state level
chapter 1. the role of the nurse practitioner answer section
multiple choice
1. ans: 3 pts: 1
2. ans: 2 pts: 1
3. ans: 1 pts:1
4. ans: 2 pts: 1
5. ans: 1 pts: 1
chapter 2. review of basic principles of pharmacology
multiple choice
,identify the choice that best completes the statement or answers the question.
1. a patient’s nutritional intake and laboratory results reflect hypoalbuminemia. this is
critical to prescribing because:
1. distribution of drugs to target tissue may be affected.
2. the solubility of the drug will not match the site of absorption.
3. there will be less free drug available to generate an effect.
4. drugs bound to albumin are readily excreted by the kidneys.
2. drugs that have a significant first-pass effect:
1. must be given by the enteral (oral) route only
2. bypass the hepatic circulation
3. are rapidly metabolized by the liver and may have little if any desired action
4. are converted by the liver to more active and fat-soluble forms
3. the route of excretion of a volatile drug will likely be the:
1. kidneys
2. lungs
3. bile and feces
4. skin
4. medroxyprogesterone (depo provera) is prescribed intramuscularly (im) to create a
storage reservoir of the drug. storage reservoirs:
1. assure that the drug will reach its intended target tissue
2. are the reason for giving loading doses
3. increase the length of time a drug is available and active
4. are most common in collagen tissues
5. the np chooses to give cephalexin every 8 hours based on knowledge of the drug’s:
1. propensity to go to the target receptor
2. biological half-life
3. pharmacodynamics
, 4. safety and side effects
6. azithromycin dosing requires that the first day’s dosage be twice those of the other 4
days of the prescription. this is considered a loading dose. a loading dose:
1. rapidly achieves drug levels in the therapeutic range
2. requires four- to five-half-lives to attain
3. is influenced by renal function
4. is directly related to the drug circulating to the target tissues
7. the point in time on the drug concentration curve that indicates the first sign of a
therapeutic effect is the:
1. minimum adverse effect level
2. peak of action
3. onset of action
4. therapeutic range
8. phenytoin requires that a trough level be drawn. peak and trough levels are done:
1. when the drug has a wide therapeutic range
2. when the drug will be administered for a short time only
3. when there is a high correlation between the dose and saturation of receptor sites
4. to determine if a drug is in the therapeutic range
9. a laboratory result indicates that the peak level for a drug is above the minimum toxic
concentration. this means that the:
1. concentration will produce therapeutic effects
2. concentration will produce an adverse response
3. time between doses must be shortened
4. duration of action of the drug is too long
10. drugs that are receptor agonists may demonstrate what property?
Pharmacotherapeutics For Advanced Practice Nurse Prescribers Fifth Edition
By Teri Moser Woo & Marylou V. Robinson( All Chapters Covered 1-55 With
Answer Section)
,table of contents
chapter 1. the role of the nurse practitioner ........................................................................... 4
chapter 2. review of basic principles of pharmacology............................................................ 5
chapter 3. rational drug selection ........................................................................................ 16
chapter 4. legal and professional issues in prescribing.......................................................... 19
chapter 5. adverse drug reactions ........................................................................................ 22
chapter 6. pharmacoeconomics ........................................................................................... 26
chapter 7. nutrition and nutraceuticals ................................................................................ 30
chapter 8. herbal therapy and nutritional supplements ........................................................ 40
chapter 9. informatics.......................................................................................................... 43
chapter 10. pharmacoeconomics ......................................................................................... 48
chapter 11. drugs affecting the autonomic nervous system .................................................. 52
chapter 12. drugs affecting the central nervous system ........................................................ 63
chapter 13. drugs affecting the cardiovascular and renal systems ........................................ 74
chapter 14. drugs affecting the respiratory system ............................................................... 86
chapter 15. drugs affecting the hematological system ......................................................... 92
chapter 16. drugs affecting the immune system ................................................................... 97
chapter 17. drugs affecting the gastrointestinal system ..................................................... 103
chapter 18. drugs affecting the endocrine system: pancreatic hormones and antidiabetic
drugs ................................................................................................................................. 107
chapter 19. drugs affecting the endocrine system: pituitary, thyroid, and adrenal drugs .... 113
chapter 20. drugs affecting the reproductive system .......................................................... 129
chapter 21. drugs affecting the bones and joints ................................................................ 136
chapter 22. drugs affecting the integumentary system ....................................................... 145
chapter 23. drugs used in treating bacterial diseases ......................................................... 151
chapter 24. drugs used to treat viral, fungal, and protozoal infections ............................... 158
chapter 25. drugs used in treating inflammatory processes ................................................ 165
chapter 26. drugs used in treating eye and ear disorders .................................................... 170
chapter 27. alcohol and drug addiction .............................................................................. 173
chapter 28. anemia............................................................................................................ 180
chapter 29. angina ............................................................................................................ 184
,chapter 30. anxiety and depression.................................................................................... 190
chapter 31. attention deficit hyperactivity disorder ............................................................ 194
chapter 32. asthma and chronic obstructive pulmonary disease ......................................... 198
chapter 33. contraception .................................................................................................. 202
chapter 34. dermatologic conditions .................................................................................. 205
chapter 35. diabetes management .................................................................................... 210
chapter 36. gastroesophageal reflux and peptic ulcer disease ............................................ 221
chapter 37. headaches ....................................................................................................... 225
chapter 38. heart failure .................................................................................................... 230
chapter 39. human immunodeficiency virus disease and acquired immunodeficiency ......... 235
chapter 40. hormone replacement therapy ........................................................................ 239
chapter 41. hyperlipidemia ................................................................................................ 244
chapter 42. hypertension ................................................................................................... 249
chapter 43. hyperthyroidism and hypothyroidism .............................................................. 255
chapter 44. pain management: acute and chronic pain ...................................................... 259
chapter 45. pneumonia ...................................................................................................... 264
chapter 46. smoking cessation ........................................................................................... 267
chapter 47. sexually transmitted infections and vaginitis ................................................... 270
chapter 48. tuberculosis..................................................................................................... 275
chapter 49. upper respiratory infection, pharyngitis, sinusitis, otitis media, and otitis externa
......................................................................................................................................... 278
chapter 50. urinary tract infections .................................................................................... 282
chapter 51: women as patients .......................................................................................... 285
chapter 52. men as patients ............................................................................................... 290
chapter 53. pediatric patients ............................................................................................ 293
chapter 54. transgendered clients as patients .................................................................... 296
chapter 55. geriatric patients ............................................................................................. 301
,chapter 1. the role of the nurse practitioner
multiple choice
identify the choice that best completes the statement or answers the question.
1. nurse practitioner prescriptive authority is regulated by:
1. the national council of state boards of nursing
2. the u.s. drug enforcement administration
3. the state board of nursing for each state
4. the state board of pharmacy
2. the benefits to the patient of having an advanced practice registered nurse (aprn)
prescriber include:
1. nurses know more about pharmacology than other prescribers because they take it
both in their basic nursing program and in their aprn program.
2. nurses care for the patient from a holistic approach and include the patient in decision
making regarding their care.
3. aprns are less likely to prescribe narcotics and other controlled substances.
4. aprns are able to prescribe independently in all states, whereas a physician’s assistant
needs to have a physician supervising their practice.
3. clinical judgment in prescribing includes:
1. factoring in the cost to the patient of the medication prescribed
2. always prescribing the newest medication available for the disease process
3. handing out drug samples to poor patients
4. prescribing all generic medications to cut costs
4. criteria for choosing an effective drug for a disorder include:
1. asking the patient what drug they think would work best for them
2. consulting nationally recognized guidelines for disease management
3. prescribing medications that are available as samples before writing a prescription
,4. following u.s. drug enforcement administration guidelines for prescribing
5. nurse practitioner practice may thrive under health-care reform because of:
1. the demonstrated ability of nurse practitioners to control costs and improve patient
outcomes
2. the fact that nurse practitioners will be able to practice independently
3. the fact that nurse practitioners will have full reimbursement under health-care
reform
4. the ability to shift accountability for medicaid to the state level
chapter 1. the role of the nurse practitioner answer section
multiple choice
1. ans: 3 pts: 1
2. ans: 2 pts: 1
3. ans: 1 pts:1
4. ans: 2 pts: 1
5. ans: 1 pts: 1
chapter 2. review of basic principles of pharmacology
multiple choice
,identify the choice that best completes the statement or answers the question.
1. a patient’s nutritional intake and laboratory results reflect hypoalbuminemia. this is
critical to prescribing because:
1. distribution of drugs to target tissue may be affected.
2. the solubility of the drug will not match the site of absorption.
3. there will be less free drug available to generate an effect.
4. drugs bound to albumin are readily excreted by the kidneys.
2. drugs that have a significant first-pass effect:
1. must be given by the enteral (oral) route only
2. bypass the hepatic circulation
3. are rapidly metabolized by the liver and may have little if any desired action
4. are converted by the liver to more active and fat-soluble forms
3. the route of excretion of a volatile drug will likely be the:
1. kidneys
2. lungs
3. bile and feces
4. skin
4. medroxyprogesterone (depo provera) is prescribed intramuscularly (im) to create a
storage reservoir of the drug. storage reservoirs:
1. assure that the drug will reach its intended target tissue
2. are the reason for giving loading doses
3. increase the length of time a drug is available and active
4. are most common in collagen tissues
5. the np chooses to give cephalexin every 8 hours based on knowledge of the drug’s:
1. propensity to go to the target receptor
2. biological half-life
3. pharmacodynamics
, 4. safety and side effects
6. azithromycin dosing requires that the first day’s dosage be twice those of the other 4
days of the prescription. this is considered a loading dose. a loading dose:
1. rapidly achieves drug levels in the therapeutic range
2. requires four- to five-half-lives to attain
3. is influenced by renal function
4. is directly related to the drug circulating to the target tissues
7. the point in time on the drug concentration curve that indicates the first sign of a
therapeutic effect is the:
1. minimum adverse effect level
2. peak of action
3. onset of action
4. therapeutic range
8. phenytoin requires that a trough level be drawn. peak and trough levels are done:
1. when the drug has a wide therapeutic range
2. when the drug will be administered for a short time only
3. when there is a high correlation between the dose and saturation of receptor sites
4. to determine if a drug is in the therapeutic range
9. a laboratory result indicates that the peak level for a drug is above the minimum toxic
concentration. this means that the:
1. concentration will produce therapeutic effects
2. concentration will produce an adverse response
3. time between doses must be shortened
4. duration of action of the drug is too long
10. drugs that are receptor agonists may demonstrate what property?
